OakChart

Pfizer Inc

PFEHealthcare·Drug Manufacturers - General·USA·Large·NYSE·Nov 11 • 2:06 PM ET

29.31-0.06 (-0.19%)
2026-11-11 20:06 CET
Market cap
167,347.60 USD m
Revenue, TTM
63,625.00 USD m
Net income, TTM
4,033.00 USD m
Free cash flow, TTM
11,787.00 USD m
EPS diluted, TTM
0.70
P/E
41.91
Compare

Price

PFE against its 20, 50 and 200-day averages
2050200beatmiss
24.0026.0028.0030.0059.8M119.6MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PFEclose 29.3120-day 29.8550-day 28.80200-day 26.9629.3152w high52w low

6.8% under the 52-week high of 31.44 on 5 Nov 2026. 52-week low 23.62 on 25 Jun 2026. Last 15 sessions, 10.2% high to low

Profile

PFE
52-week range, 73% of the way up
23.6231.44

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

IndexS&P 500, RUI
Employees75000
IPOJan 17, 1944
Beta0.30
ATR, 14d0.71
Rel volume0.46
Short float2.36%
Insider own0.09%
Inst own69.72%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap167.03B
Enterprise Value215.73B
Income4.03B
Sales63.62B
Book/sh15.61
Cash/sh2.50
Dividend Est.1.72 (5.87%)
Dividend TTM1.72 (5.87%)
Dividend Ex-DateNov 06, 2026
Dividend Gr. 3/5Y2.23% 2.37%
Payout126.85%
Employees75000
IPOJan 17, 1944

Ratios

P/E41.91
Forward P/E9.96
PEG-
P/S2.63
P/B1.88
P/C11.70
P/FCF14.17
EV/EBITDA9.37
EV/Sales3.39
Quick Ratio1.10
Current Ratio1.42
Debt/Eq0.70
LT Debt/Eq0.67
Option/ShortYes / Yes

Earnings

EPS (ttm)0.70
EPS next Y2.94
EPS next Q0.69
EPS this Y-5.61%
EPS next Y-3.22%
EPS next 5Y-8.41%
EPS past 3/5Y-37.19% -3.57%
Sales past 3/5Y-14.56% 8.48%
EPS Y/Y TTM-58.96%
Sales Y/Y TTM1.34%
EPS Q/Q-9.04%
Sales Q/Q-0.43%
EarningsNov 03 BMO
EPS/Sales Surpr.18.29% 4.61%

Ownership

Insider Own0.09%
Insider Trans2.18%
Inst Own69.72%
Inst Trans-1.06%
ROA1.95%
ROE4.44%
ROIC2.71%
Gross Margin65.10%
Oper. Margin25.95%
Profit Margin6.34%
SMA20-1.83%
SMA501.75%
SMA2008.72%
Trades-

Technical

Shs Outstand5.70B
Shs Float5.69B
Short Float2.36%
Short Ratio3.97
Short Interest134.42M
52W High31.44 -6.79%
52W Low23.62 24.07%
Volatility3.01% 2.24%
ATR (14)0.71
RSI (14)48.81
Beta0.30
Rel Volume0.46
Avg Volume33.83M
Volume11,279,686

Performance

Perf Week-4.82%
Perf Month3.30%
Perf Quarter9.35%
Perf Half Y12.89%
Perf YTD17.69%
Perf Year14.88%
Perf 3Y-0.59%
Perf 5Y-41.60%
Perf 10Y-5.12%
Recom2.60
Target Price30.07
Prev Close29.36
Price29.31
Change %-0.19%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 06, 2026DowngradeDDZ BankBuy → Hold
Jul 06, 2026DowngradeHHSBC SecuritiesBuy → Hold$28-4.5%
Jun 10, 2026UpgradeRRBC Capital MktsUnderperform → Sector Perform$25-14.7%
Mar 02, 2026UpgradeAArgusHold → Buy$35+19.4%
Feb 25, 2026InitiatedRRBC Capital MktsUnderperform$25-14.7%
Feb 20, 2026InitiatedBBarclaysUnderweight$25-14.7%
Feb 12, 2026DowngradeDDaiwa SecuritiesOutperform → Neutral$27-7.9%
Jan 07, 2026ResumedUUBSNeutral$25-14.7%
Dec 02, 2025ResumedCCitigroupNeutral$26-11.3%
Nov 13, 2025InitiatedBScotiabankSector Outperform$30+2.4%

Peers

Mkt cap
TickerCompanyMkt cap
GSKGSK Plc ADR100.87B
AZNAstrazeneca plc286.61B
BMYBristol-Myers Squibb Co127.29B
MRKMerck & Co Inc360.92B
SNYSanofi ADR114.65B
NVSNovartis AG ADR292.36B
ABBVAbbvie Inc517.40B
JNJJohnson & Johnson671.86B
AMGNAMGEN Inc250.66B
LLYLilly(Eli) & Co1345.11B

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
BOURLA ALBERTChairman & CEOAug 12 '26Buy26.3438,0001,000,920429,173Aug 12 04:04 PM
DAMICO JENNIFER B.SVP & ControllerAug 05 '26Sale25.403,27883,26128,611Aug 06 11:26 AM
BLAYLOCK RONALD EDirectorAug 05 '26Buy25.4639,231998,82166,938Aug 05 04:03 PM
Buckley Mortimer JDirectorAug 05 '26Buy25.5237,632960,36937,632Aug 05 04:02 PM
DAMICO JENNIFER B.SVP & ControllerJun 09 '26Sale25.702,00051,40031,397Jun 10 07:58 PM
SAHNI PAYALExecutive Vice PresidentFeb 25 '26Option Exercise33.8256,8881,923,95282,816Feb 27 06:35 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25 '26Option Exercise33.82122,9074,156,715282,186Feb 27 06:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25 '26Option Exercise33.8217,558593,81229,744Feb 27 06:35 PM
BOURLA ALBERTChairman & CEOFeb 25 '26Option Exercise33.82491,62616,626,791864,215Feb 27 06:34 PM
Fonseca LidiaExecutive Vice PresidentFeb 25 '26Option Exercise33.8256,8881,923,952101,579Feb 27 06:34 PM
McDermott MichaelExecutive Vice PresidentFeb 25 '26Option Exercise33.8237,9251,282,624114,534Feb 27 06:34 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
HDViShares Core High Dividend ETFAUM: 16.41B
HDViShares Core High Dividend ETFAUM: 16.41B
VYMVanguard High Dividend Yield Indx ETFAUM: 83.15B
DVYiShares Select Dividend ETFAUM: 23.68B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-030.8700.7360.56016,58315,85220
2026Q22026-08-040.7700.682-0.04415,03414,39920
2026Q12026-05-050.7500.7220.46914,45113,84020
2025Q42026-02-030.6600.567-0.29017,55716,84917
2025Q32025-11-040.8700.6330.62016,65416,49815
2025Q22025-08-050.7800.5800.50614,65313,56014
2025Q12025-04-290.9200.6660.52013,71513,92014
2024Q42025-02-040.6300.4720.07117,76317,35016
2024Q32024-10-291.0600.6140.78417,70214,92116
2024Q22024-07-300.6000.4580.00413,28312,96117
2024Q12024-05-010.8200.5160.54814,87913,87415
2023Q42024-01-300.100-0.158-0.59214,24914,36916
2023Q32023-10-31-0.170-0.080-0.42413,23213,34016
2023Q22023-08-010.6700.5700.40812,73413,36317
2023Q12023-05-021.2300.9840.96818,28216,60716
2022Q42023-01-311.1401.0470.86924,29024,38216

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY2.9502.9692.86851,75051,680
2020FY2.2202.8311.62641,90848,202
2021FY4.4204.2083.88081,28881,765
2022FY6.5806.5035.471100,330100,342
2023FY1.8401.5470.37458,49658,778
2024FY3.1102.9261.40763,62763,083
2025FY3.2203.1201.36062,57961,936
2026FY-3.039--63,045
2027FY-2.942--60,588
2028FY-2.474--55,215
2029FY-2.284--53,638
2030FY-2.347--54,337

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-051610217,19916,62417,908
2026Q4S2026-11-03169217,15116,48217,908
2026Q4S2026-10-30162616,87316,40017,803
2026Q4S2026-10-21163516,88516,40017,803
2026Q4S2026-10-20163616,88816,40017,803
2026Q4S2026-10-18162616,84216,11617,803
2026Q4S2026-10-16162916,84216,11617,803
2026Q4S2026-10-15162916,84216,11617,803
2026Q4S2026-10-12162916,84216,11617,803
2026Q4S2026-10-09162916,83516,11617,803
2026Q4S2026-10-08162816,84916,11617,803
2026Q4S2026-10-07164616,89316,11617,937
2026Q4S2026-10-06164416,92016,11617,937
2026Q4S2026-10-05164416,92016,11617,937

Estimate history

EPS, annual3.5171.8662.8681.6263.885.4710.3741.4071.3560.6992
Period201720182019202020212022202320242025TTM
EPS, quarterly0.7840.0710.520.5060.62-0.290.469-0.0440.564
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual525465364741172416518128810033059553636276257963625
Period201720182019202020212022202320242025TTM
Sales, quarterly177021776313715146531665417557144511503416583
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual5979571755345567562056165646566756865700
Period201720182019202020212022202320242025MRQ
Shares, quarterly566656675685568556865686569956995700
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue63,625.0062,579.0063,627.0059,553.00100,330.0081,288.0041,651.0041,172.0053,647.00
Cost of Goods Sold Incl. D&A22,208.0021,544.0021,781.0029,213.0038,240.0034,413.0011,771.0012,623.0016,008.00
Gross Profit41,417.0041,035.0041,846.0030,340.0062,090.0046,875.0029,880.0028,549.0037,639.00
Selling, General and Administrative Excl. Other24,904.0023,929.0025,363.0025,048.0024,541.0026,082.0020,795.0021,038.0022,350.00
Research and Development11,287.0010,247.0010,738.0010,578.0011,426.0013,828.009,395.008,364.007,967.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income16,513.0017,106.0016,483.005,292.0037,549.0020,793.009,085.007,511.0015,289.00
Interest Expense2,708.002,671.003,091.002,209.001,238.001,291.001,449.001,573.001,316.00
Unusual Expense12,785.008,749.008,006.007,474.002,120.00-176.001,645.004,079.003,622.00
Net Income Before Taxes4,260.007,520.008,023.001,058.0034,729.0024,311.007,036.0011,485.0011,885.00
Income Taxes186.00-267.00-28.00-1,114.003,328.001,852.00370.00618.00706.00
Consolidated Net Income4,074.007,787.008,051.002,172.0031,401.0022,460.006,666.0010,867.0011,179.00
Net Income From Continuing Operations4,037.007,746.008,020.002,133.0031,366.0022,415.006,630.0010,838.0011,143.00
Net Income4,033.007,771.008,020.002,134.0031,365.0022,146.009,159.0016,272.0011,152.00
EPS (Recurring)2.262.432.391.295.733.861.833.372.29
EPS (Basic, Before Extraordinaries)0.711.361.420.385.593.951.652.921.90
EPS (Diluted)0.701.361.410.375.473.881.632.871.87
EBITDA23,012.0023,698.0023,496.0011,582.0042,613.0025,984.0013,766.0013,306.0021,673.00
Non-Operating Income (Expense)3,243.001,834.002,637.005,449.00538.004,633.001,047.009,626.001,534.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-659.00712.00432.00712.00971.00614.00551.00769.00
Price To Earnings Ratio41.9941.9935.6615.819.8715.3321.5312.9422.23
Price To Sales Ratio2.592.272.382.762.934.154.985.404.86
Gross Margin65.1065.5765.7750.9561.8957.6771.7469.3470.16
Operating Margin25.9527.3425.918.8937.4325.5821.8118.2428.50
Net Margin6.3412.4212.603.5831.2627.2421.9939.5220.79
Shares Outstanding5,700.005,686.005,667.005,646.005,616.005,620.005,567.005,534.005,717.00
Market Capitalization167,347.60167,347.60150,345.24162,560.14287,626.00331,439.97204,604.70205,400.16239,020.92

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue16,583.0015,034.0014,451.0017,557.0016,654.0014,653.0013,715.0017,763.00
Cost of Goods Sold Incl. D&A5,278.005,572.004,817.006,541.005,471.005,233.003,888.004,795.00
Gross Profit11,305.009,462.009,634.0011,016.0011,183.009,420.009,827.0012,968.00
Selling, General and Administrative Excl. Other6,189.006,105.005,383.007,227.005,653.005,845.005,203.007,243.00
Research and Development2,956.002,746.002,452.003,133.002,492.002,443.002,179.003,017.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income5,116.003,357.004,251.003,789.005,530.003,575.004,624.005,725.00
Interest Expense662.00667.00668.00711.00652.00654.00654.00739.00
Unusual Expense1,331.005,492.00404.005,558.002,117.00186.001,338.003,968.00
Net Income Before Taxes3,385.00-653.003,170.00-1,642.003,334.003,044.002,784.00-10.00
Income Taxes134.00-407.00461.00-2.00-216.00141.00-189.00-421.00
Consolidated Net Income3,251.00-246.002,709.00-1,640.003,550.002,903.002,973.00411.00
Net Income From Continuing Operations3,241.00-256.002,700.00-1,648.003,541.002,885.002,967.00403.00
Net Income3,242.00-248.002,687.00-1,648.003,541.002,885.002,967.00403.00
EPS (Recurring)0.730.630.520.390.880.530.680.56
EPS (Basic, Before Extraordinaries)0.57-0.040.47-0.290.620.510.520.07
EPS (Diluted)0.56-0.040.47-0.290.620.510.520.07
EBITDA6,693.004,979.005,864.005,476.007,192.005,200.006,242.007,516.00
Non-Operating Income (Expense)262.002,150.00-7.00838.00573.00309.00152.001,595.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Earnings Ratio41.9918.4620.7214.5113.5517.5718.0035.66
Price To Sales Ratio2.592.172.452.262.162.162.302.38
Gross Margin68.1762.9466.6762.7467.1564.2971.6573.01
Operating Margin30.8522.3329.4221.5833.2124.4033.7132.23
Net Margin19.55-1.6518.59-9.3921.2619.6921.632.27
Shares Outstanding5,700.005,699.005,699.005,686.005,686.005,685.005,685.005,667.00
Market Capitalization167,347.60137,242.52159,670.46141,574.18144,867.81137,813.37143,714.54150,345.24

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments13,596.0020,477.0012,690.0022,732.0031,069.0012,223.009,646.0018,833.0020,006.00
Short Term Receivables11,874.0011,463.0011,566.0010,952.0011,479.007,913.006,772.008,025.008,221.00
Inventories10,654.0010,851.0010,189.008,981.009,059.008,020.007,068.007,508.007,578.00
Other Current Assets6,774.007,567.008,888.008,594.008,086.006,910.009,317.0015,560.005,336.00
Total Current Assets42,898.0050,358.0043,333.0051,259.0059,693.0035,067.0032,803.0049,926.0041,141.00
Net Property, Plant & Equipment21,530.0020,682.0021,864.0019,276.0017,721.0015,131.0014,258.0013,385.0013,865.00
Total Investments and Advances1,737.002,687.0015,770.0015,433.0021,526.0020,262.0020,147.002,767.007,090.00
Intangible Assets124,995.00123,938.00132,683.0094,745.0074,354.0077,893.0082,138.0088,622.00104,693.00
Deferred Tax Assets9,699.008,662.003,706.006,693.003,341.002,383.001,911.001,924.001,855.00
Other Assets7,301.007,069.009,145.009,799.004,840.003,493.0016,337.002,798.003,153.00
Total Assets208,160.00213,396.00226,501.00197,205.00181,476.00154,229.00167,594.00159,422.00171,797.00
Short Term Debt Incl. Current Port. of LT Debt3,484.007,302.0010,877.003,565.002,690.003,023.0016,464.008,831.009,953.00
Accounts Payable5,240.005,633.006,710.006,809.005,578.004,283.003,887.004,674.004,656.00
Income Tax Payable3,103.002,910.002,349.001,587.001,266.001,049.00980.001,265.00477.00
Other Current Liabilities25,157.0027,150.0027,858.0030,177.0033,137.0017,565.0015,973.0017,088.0015,341.00
Total Current Liabilities36,984.0042,995.0047,794.0042,138.0042,671.0025,920.0037,304.0031,858.0030,427.00
Long Term Debt63,932.0059,691.0064,164.0035,481.0038,705.0038,241.0036,985.0032,909.0033,538.00
Provision for Risks Charges6,098.008,664.0011,364.0012,062.0015,055.0016,971.0018,343.0021,347.0026,127.00
Deferred Tax Liabilities2,401.002,122.00640.001,023.00349.004,063.005,652.003,700.003,900.00
Other Liabilities11,970.0011,427.0013,251.0010,584.007,233.005,561.005,864.005,850.006,149.00
Total Liabilities121,385.00124,899.00137,213.00101,288.00104,013.0090,756.00104,148.0095,664.00100,141.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.0017.0019.0021.00
Common Equity86,476.0088,203.0089,014.0095,661.0077,201.0063,238.0063,126.0063,388.0071,287.00
Total Shareholders Equity86,476.0088,203.0089,014.0095,661.0077,201.0063,238.0063,143.0063,407.0071,308.00
Accumulated Minority Interest299.00294.00274.00256.00262.00235.00303.00351.00348.00
Total Equity86,775.0088,497.0089,288.0095,917.0077,463.0063,473.0063,446.0063,758.0071,656.00
Total Liabilities & Stockholders Equity208,160.00213,396.00226,501.00197,205.00181,476.00154,229.00167,594.00159,422.00171,797.00
Book Value Per Share15.2115.5615.7717.0313.7411.3611.4111.0911.92
Tangible Book Value Per Share-6.77-6.31-7.730.160.51-2.63-3.44-4.41-5.59
Full-Time Employees75,00081,00088,00083,00079,00078,50088,30092,40090,200
Price to Book Ratio1.881.631.683.104.303.243.253.733.37
Return on Assets3.673.651.0116.5713.354.126.636.7312.41
Return on Equity8.879.052.3136.2931.9210.4917.1316.5432.57
Return on Invested Capital5.175.421.3923.9219.119.0316.2511.5820.32
Quick Ratio0.870.920.691.001.191.040.691.331.10
Current Ratio1.161.170.911.221.401.350.881.571.35

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income4,074.007,787.008,062.002,158.0031,401.0022,025.009,195.0016,302.0011,188.00
Depreciation6,499.006,592.007,013.006,290.005,064.005,191.004,681.005,795.006,384.00
Other Funds (Non Cash)6,839.004,813.002,837.005,866.004,982.00-3,147.002,409.00-6,152.001,387.00
Funds from Operations14,787.0017,059.0015,810.0010,872.0037,683.0019,776.0014,710.0016,541.0016,754.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-613.00-5,354.00-3,066.00-2,172.00-4,456.0012,804.00-307.00-3,953.00-927.00
Cash from Operating Activities14,174.0011,705.0012,744.008,700.0033,227.0032,580.0014,403.0012,588.0015,827.00
Capital Expenditures-2,387.00-2,629.00-2,909.00-3,907.00-3,236.00-2,711.00-2,226.00-2,490.00-2,196.00
Net Assets From Acquisitions-6,927.00-6,927.000.00-43,430.00-22,997.000.000.00-10,861.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments4,070.008,040.005,561.0015,239.006,682.00-19,517.00-1,672.009,304.006,434.00
Purchase of Investments-10,485.00-14,650.00-10,313.00-31,178.00-38,780.00-47,613.00-14,402.00-7,036.00-17,391.00
Sale Or Maturity of Investments14,555.0022,690.0015,874.0046,417.0045,462.0028,096.0012,730.0016,340.0023,825.00
Other Uses0.000.00-2.00-180.00-192.00-317.00-374.00-94.000.00
Other Sources-37.00165.002.000.000.000.000.00196.00287.00
Cash from Investing Activities-5,281.00-1,351.002,652.00-32,278.00-19,743.00-22,546.00-4,271.00-3,945.004,525.00
Cash Dividends Paid-9,792.00-9,771.00-9,512.00-9,247.00-8,983.00-8,729.00-8,440.00-8,043.00-7,978.00
Change in Capital Stock0.000.000.000.00-2,000.000.000.00-8,471.00-10,939.00
Repurchase of Common Pref Stock0.000.000.000.00-2,000.000.000.00-8,865.00-12,198.00
Sale of Common Pref Stock0.000.000.000.000.000.000.00394.001,259.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net1,748.00-74.00-7,159.0035,945.00-3,516.00-1,103.00-12,755.008,764.00-935.00
Change in Long Term Debt1,734.002,921.00-2,250.0028,262.00-3,298.00-1,007.001,219.00-1,864.001,408.00
Issuance of Long Term Debt5,991.009,678.000.0030,831.000.00997.005,222.004,942.004,974.00
Reduction of Long Term Debt-4,257.00-6,757.00-2,250.00-2,569.00-3,298.00-2,004.00-4,003.00-6,806.00-3,566.00
Net Financing Active Other Cash Flow-385.00-459.00-469.00-632.00-335.0016.0011,547.00-735.00-589.00
Other Financing Activities Uses-385.00-459.00-469.00-632.00-335.000.00-444.00-735.00-589.00
Cash from Financing Activities-8,429.00-10,304.00-17,140.0026,066.00-14,834.00-9,816.00-9,649.00-8,485.00-20,441.00
Exchange Rate Effect21.0041.00-66.00-40.00-165.00-59.00-8.00-32.00-116.00
Net Change in Cash485.0091.00-1,810.002,448.00-1,515.00159.00475.00126.00-205.00
Free Cash Flow11,787.009,076.009,835.004,793.0029,991.0029,869.0012,177.0010,516.0013,785.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00--
Price to Free Cash Flow82.65-468.18-13.9815.9455.4889.9144.93
Deferred Taxes & Investment Tax Credit--2,133.00-2,102.00-3,442.00-3,764.00-4,293.00-1,575.00596.00-2,205.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments14,272.0011,699.0013,075.0013,596.0014,984.0013,249.00
Short Term Receivables14,192.0012,490.0012,585.0011,874.0014,260.0012,078.00
Inventories10,022.009,945.0010,667.0010,654.0011,468.0011,669.00
Other Current Assets6,523.007,224.006,496.006,774.006,213.006,706.00
Total Current Assets45,009.0041,358.0042,823.0042,898.0046,925.0043,702.00
Net Property, Plant & Equipment19,048.0019,029.0019,402.0021,530.0018,880.0018,776.00
Total Investments and Advances1,601.001,744.001,781.001,737.002,476.002,206.00
Intangible Assets117,420.00118,472.00123,968.00124,995.00120,425.00121,699.00
Deferred Tax Assets11,591.0010,774.009,965.009,699.0011,048.0010,343.00
Other Assets9,875.009,754.009,679.007,301.008,978.009,369.00
Total Assets204,544.00201,131.00207,618.00208,160.00208,731.00206,095.00
Short Term Debt Incl. Current Port. of LT Debt2,674.002,699.003,890.003,484.004,303.004,295.00
Accounts Payable4,070.004,581.004,506.005,240.005,024.005,166.00
Income Tax Payable438.00653.003,130.003,103.003,799.003,675.00
Other Current Liabilities24,544.0024,713.0022,822.0025,157.0023,470.0024,590.00
Total Current Liabilities31,726.0032,646.0034,348.0036,984.0036,596.0037,726.00
Long Term Debt59,997.0060,495.0060,565.0063,932.0057,409.0057,502.00
Provision for Risks Charges7,140.006,463.006,120.006,098.006,090.006,128.00
Deferred Tax Liabilities1,936.001,964.002,412.002,401.002,467.002,481.00
Other Liabilities14,445.0014,070.0013,769.0011,970.0013,073.0013,246.00
Total Liabilities115,244.00115,638.00117,214.00121,385.00115,635.00117,083.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity89,001.0085,190.0090,101.0086,476.0092,801.0088,695.00
Total Shareholders Equity89,001.0085,190.0090,101.0086,476.0092,801.0088,695.00
Accumulated Minority Interest299.00302.00303.00299.00295.00317.00
Total Equity89,300.0085,492.0090,404.0086,775.0093,096.0089,012.00
Total Liabilities & Stockholders Equity204,544.00201,130.00207,618.00208,160.00208,731.00206,095.00
Book Value Per Share15.6114.9515.8115.2116.3215.60
Tangible Book Value Per Share-4.99-5.84-5.94-6.77-4.86-5.81
Full-Time Employees---75,000--
Price to Book Ratio1.881.521.851.531.631.53
Return on Assets1.952.133.603.674.585.08
Return on Equity4.444.998.298.8710.5912.16
Return on Invested Capital2.18-0.171.78-1.102.361.97
Quick Ratio1.100.960.940.870.970.85
Current Ratio1.421.271.251.161.281.16

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income3,251.00-246.002,709.00-1,640.003,551.002,903.00
Depreciation1,577.001,622.001,613.001,687.001,662.001,625.00
Other Funds (Non Cash)62.002,595.0037.004,145.00191.00151.00
Funds from Operations4,030.002,651.004,347.003,759.004,639.004,407.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1,345.00-1,816.00-1,732.001,590.00-36.00-4,989.00
Cash from Operating Activities5,375.00835.002,615.005,349.004,603.00-582.00
Capital Expenditures-573.00-533.00-436.00-845.00-602.00-618.00
Net Assets From Acquisitions0.000.000.00-6,927.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-1,532.002,640.001,199.001,763.00-1,840.004,578.00
Purchase of Investments-4,401.00-1,743.00-3,465.00-876.00-4,935.00-2,030.00
Sale Or Maturity of Investments2,869.004,383.004,664.002,639.003,095.006,608.00
Other Uses0.000.000.000.000.000.00
Other Sources79.00-1.0022.00-137.0012.00-10.00
Cash from Investing Activities-2,026.002,106.00785.00-6,146.00-2,430.003,951.00
Cash Dividends Paid-2,451.00-2,451.00-2,445.00-2,445.00-2,444.00-2,445.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-24.00-1,186.00-127.003,085.006.00-731.00
Change in Long Term Debt0.00-1,250.000.002,984.000.00-63.00
Issuance of Long Term Debt0.000.000.005,991.000.003,687.00
Reduction of Long Term Debt0.00-1,250.000.00-3,007.000.00-3,750.00
Net Financing Active Other Cash Flow-30.00-27.00-284.00-44.00-38.00-21.00
Other Financing Activities Uses-30.00-27.00-284.00-44.00-38.00-21.00
Cash from Financing Activities-2,506.00-3,663.00-2,856.00596.00-2,476.00-3,197.00
Exchange Rate Effect1.00-4.0019.005.002.0041.00
Net Change in Cash844.00-726.00563.00-196.00-301.00213.00
Free Cash Flow4,802.00302.002,179.004,504.004,001.00-1,200.00
Price to Free Cash Flow82.65115.26--202.6349.37

Revenue breakdown

International Developed Markets2024: 16.06B 2025: 16.19B
International Emerging Markets2024: 8.88B 2025: 9.31B
United States2024: 38.69B 2025: 37.08B
Biopharma2024: 62.40B 2025: 61.20B
Consolidation, Policy2024: 1.23B 2025: 1.38B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.36%134.4M5695.0M33.93M
2026-10-152.42%137.8M5694.8M35.40M
2026-09-302.64%150.2M5694.8M37.34M
2026-09-152.73%155.2M5694.6M41.66M
2026-08-312.66%151.5M5694.6M42.11M
2026-08-142.62%149.3M5694.8M41.94M
2026-07-312.84%161.5M5693.3M41.32M
2026-07-152.88%163.8M5692.9M40.73M
2026-06-302.87%163.6M5692.9M39.30M
2026-06-152.85%162.1M5686.4M36.54M
2026-05-292.86%162.7M5692.9M37.40M
2026-05-152.77%157.5M5692.9M37.72M
2026-04-302.46%140.3M5695.8M40.93M
2026-04-152.35%133.4M5684.6M43.73M
2026-03-312.33%132.5M5680.7M46.04M
2026-03-132.31%131.4M5680.7M47.13M
2026-02-272.51%142.8M5680.7M47.55M
2026-02-132.58%146.4M5680.1M51.71M
2026-01-302.52%143.0M5680.6M63.25M
2026-01-152.29%129.8M5680.6M63.27M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call15.0013.9014.4014.225.0887.001.000.996-0.0200.000
call18.0011.1511.3511.253.44011.000.000.995-0.0200.000
call19.0010.0510.4010.223.48211.003.000.994-0.0190.000
call20.009.059.609.263.9899.000.000.993-0.0190.000
call21.008.058.358.232.46822.0016.000.993-0.0190.000
call22.007.057.407.252.46122.0015.000.992-0.0180.000
call23.006.056.406.242.14419.0026.000.990-0.0180.001
call23.505.555.905.721.98820.0013.000.990-0.0180.001
call24.005.055.455.262.0158.0017.000.989-0.0170.001
call24.504.654.854.731.3446.003.000.988-0.0170.001
call25.004.054.404.281.53115.0011.000.987-0.0170.001
call25.503.553.903.901.3806.008.000.985-0.0160.001
call26.003.053.503.301.4916.006.000.983-0.0160.001
call26.502.532.932.681.15914.000.000.979-0.0170.001
call27.002.062.402.210.92715.002.000.970-0.0210.001
call27.501.571.871.550.69927.001.000.960-0.0220.002
call28.001.171.321.210.4071313.000.958-0.0160.002
call28.500.740.840.780.27835163.000.894-0.0300.004
call29.000.390.420.380.2611,0783530.690-0.0550.007
call29.500.140.150.140.2676,1082,9310.380-0.0620.008
call30.000.030.040.030.2895,3791,0770.177-0.0490.006
call30.500.010.020.010.35616,3323070.145-0.0650.005
call31.000.000.020.010.4104,33639.000.074-0.0410.003
call31.500.000.010.010.5046,6127.000.043-0.0290.002
call32.000.000.010.010.5984,4570.000.025-0.0190.001
call32.500.000.010.010.5569,4810.000.019-0.0120.001
call33.000.000.010.010.6261,1151.000.018-0.0120.001
call33.500.000.010.010.8311110.000.016-0.0170.001
call34.000.000.100.100.9272250.000.015-0.0190.001
call34.500.000.600.001.0040.000.000.014-0.0190.001
call35.000.000.010.011.0531,5611.000.013-0.0180.001
call36.000.000.020.011.0066.000.000.012-0.0140.001
call37.000.000.020.001.1210.000.000.010-0.0140.001
call38.000.000.020.001.2310.000.000.010-0.0150.001
call39.000.001.550.011.3375.000.000.009-0.0150.001
call40.000.002.130.001.7480.000.000.008-0.0220.000
put15.000.000.010.013.0262.000.00-0.004-0.0160.000
put18.000.002.130.062.6902.000.00-0.005-0.0220.000
put19.000.002.130.012.3542.000.00-0.006-0.0210.000
put20.000.002.130.002.1540.000.00-0.006-0.0210.000
put21.000.000.020.021.75812.000.00-0.012-0.0250.001
put22.000.000.020.011.54111.000.00-0.014-0.0250.001
put23.000.000.030.001.3315.000.00-0.016-0.0240.001
put23.500.002.130.001.3380.000.00-0.010-0.0200.001
put24.000.000.040.011.2224030.00-0.011-0.0190.001
put24.500.000.080.011.11046.000.00-0.012-0.0190.001
put25.000.000.030.011.00053.000.00-0.013-0.0190.001
put25.500.000.060.010.8901951.00-0.015-0.0180.001
put26.000.000.060.030.7812081.00-0.016-0.0180.001
put26.500.000.010.010.7394720.00-0.067-0.0580.003
put27.000.000.030.010.5653046.00-0.030-0.0230.001
put27.500.000.030.010.4562,40377.00-0.040-0.0240.002
put28.000.000.010.010.3281,131141-0.068-0.0290.003
put28.500.020.040.050.3233,483163-0.106-0.0310.004
put29.000.110.140.130.3117,621625-0.309-0.0570.007
put29.500.340.390.390.3376,35370.00-0.620-0.0640.008
put30.000.740.830.810.4423,82838.00-0.823-0.0510.006
put30.501.181.521.380.89583227.00-0.854-0.0660.005
put31.001.611.971.770.99185.005.00-0.925-0.0430.003
put31.502.172.422.341.0617.004.00-0.957-0.0300.002
put32.002.562.942.831.2397.004.00-0.973-0.0220.001
put32.503.153.403.351.2961.006.00-0.981-0.0190.001
put33.003.653.903.841.4221.004.00-0.982-0.0190.001
put33.504.154.404.351.5431.006.00-0.984-0.0200.001
put34.004.655.104.912.0642.001.00-0.985-0.0200.001
put34.505.155.555.342.0963.002.00-0.986-0.0200.001
put35.005.606.155.902.4342.001.00-0.987-0.0210.001
put36.006.656.906.832.0922.006.00-0.988-0.0210.001
put37.007.657.907.832.2912.002.00-0.989-0.0210.001
put38.008.658.908.832.4802.006.00-0.990-0.0220.001
put39.009.659.909.822.6611.002.00-0.991-0.0220.001
put40.0010.6510.9010.832.8341.006.00-0.991-0.0220.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-038-KCurrent report2026-10-30SEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-27SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-16SCHEDULE 13GSEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-31SEC
2026-08-31N-PXAnnual Report of Proxy Voting Record of Registered Management Investment Companies filed on Form N-PX2026-06-30SEC
2026-08-283Initial statement of beneficial ownership of securities2026-08-17SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-1313F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-06-30SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-28SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-134Statement of changes in beneficial ownership of securities2026-07-09SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-082.96M383.26K1
2026-070000
2026-060051.40K1
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.9.29%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP5.39%
GEODE CAPITAL MANAGEMENT, LLC2.41%
VANGUARD PORTFOLIO MANAGEMENT LLC2.09%
Fisher Asset Management, LLC1.97%
MORGAN STANLEY1.69%
NORGES BANK1.08%
NORTHERN TRUST CORP1.04%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/0.99%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
iShares Core S&P 500 ETF1.37%
Fidelity 500 Index Fund1.30%
VANGUARD WELLINGTON FUND1.23%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND1.23%
SPDR S&P 500 ETF TRUST1.21%
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND1.02%
VANGUARD VALUE INDEX FUND0.95%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND0.79%

OakChart. PFE. Cached 15 minutes.